{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:13:25Z","timestamp":1786605205992,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AR070604"],"award-info":[{"award-number":["P50 AR070604"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtm.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T12:21:14Z","timestamp":1612873274000},"page":"274-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A"],"prefix":"10.1016","volume":"21","author":[{"given":"Davin","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.02.004_bib1","first-page":"351","article-title":"Congenital muscular dystrophy with merosin deficiency","volume":"317","author":"Tom\u00e9","year":"1994","journal-title":"C.\u00a0R. Acad. Sci. III"},{"key":"10.1016\/j.omtm.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/hmg\/3.9.1657","article-title":"Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping","volume":"3","author":"Hillaire","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nmd.2010.02.001","article-title":"Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations","volume":"20","author":"Geranmayeh","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-0004.2008.01068.x","article-title":"LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients","volume":"74","author":"Oliveira","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(99)00033-4","article-title":"Distribution of ten laminin chains in dystrophic and regenerating muscles","volume":"9","author":"Patton","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1073\/pnas.0700942104","article-title":"The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy","volume":"104","author":"Hall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.02.004_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00123482","article-title":"The morphology and mechanical properties of endomysium in series-fibred muscles: variations with muscle length","volume":"15","author":"Purslow","year":"1994","journal-title":"J.\u00a0Muscle Res. Cell Motil."},{"key":"10.1016\/j.omtm.2021.02.004_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1242\/jeb.201.5.683","article-title":"Non-myotendinous force transmission in rat extensor digitorum longus muscle","volume":"201","author":"Huijing","year":"1998","journal-title":"J.\u00a0Exp. Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.110.3.825","article-title":"Terminal short arm domains of basement membrane laminin are critical for its self-assembly","volume":"110","author":"Schittny","year":"1990","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1083\/jcb.137.3.671","article-title":"Agrin binds to the nerve-muscle basal lamina via laminin","volume":"137","author":"Denzer","year":"1997","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1432-1033.1989.tb15013.x","article-title":"Binding of nidogen and the laminin-nidogen complex to basement membrane collagen type IV","volume":"184","author":"Aumailley","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtm.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"23593","DOI":"10.1016\/S0021-9258(18)54324-6","article-title":"Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin","volume":"266","author":"von der Mark","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.02.004_bib13","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1016\/S0021-9258(18)82427-9","article-title":"Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin","volume":"268","author":"Gee","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.02.004_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng0598-94","article-title":"Mutations in the integrin alpha7 gene cause congenital myopathy","volume":"19","author":"Hayashi","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0092-8674(02)00907-8","article-title":"Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration","volume":"110","author":"Cohn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.02.004_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.21523","article-title":"Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy","volume":"65","author":"Girgenrath","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.109.160754","article-title":"Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency","volume":"331","author":"Erb","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib18","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI22928","article-title":"Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy","volume":"114","author":"Girgenrath","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/ddi095","article-title":"Muscle-specific BCL2 expression ameliorates muscle disease in laminin alpha2-deficient, but not in dystrophin-deficient, mice","volume":"14","author":"Dominov","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1172\/JCI3705","article-title":"Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models","volume":"102","author":"Kuang","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ajpath.2011.12.019","article-title":"Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy","volume":"180","author":"Rooney","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2021.02.004_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/hmg\/ddt428","article-title":"Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy","volume":"23","author":"Van Ry","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm.4367","article-title":"Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism","volume":"23","author":"Kemaladewi","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/hmg\/ddh190","article-title":"Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice","volume":"13","author":"Gawlik","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.febslet.2006.02.027","article-title":"Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan","volume":"580","author":"Gawlik","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddl201","article-title":"Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy","volume":"15","author":"Gawlik","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"eaal4649","DOI":"10.1126\/scitranslmed.aal4649","article-title":"Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice","volume":"9","author":"Reinhard","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35095054","article-title":"An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy","volume":"413","author":"Moll","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","article-title":"Quantitative analysis of the packaging capacity of recombinant adeno-associated virus","volume":"7","author":"Dong","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1083\/jcb.124.3.381","article-title":"Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues","volume":"124","author":"Vuolteenaho","year":"1994","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/75080","article-title":"A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation","volume":"6","author":"Duan","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.02.004_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.02.004_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ymthe.2004.09.013","article-title":"Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury","volume":"11","author":"Liu","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.mt.6300144","article-title":"Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure","volume":"15","author":"Townsend","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1089\/10430340260185085","article-title":"Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice","volume":"13","author":"Watchko","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI36612","article-title":"Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy","volume":"119","author":"Lai","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.02.004_bib38","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0006-291X(02)00362-5","article-title":"Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene","volume":"293","author":"Sakamoto","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2021.02.004_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2021.02.004_bib40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0896-6273(00)80096-3","article-title":"Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor","volume":"16","author":"Gesemann","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2021.02.004_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1471-4159.2002.01102.x","article-title":"Mapping sites responsible for interactions of agrin with neurons","volume":"83","author":"Burgess","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtm.2021.02.004_bib42","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1242\/dev.124.19.3909","article-title":"Integrins mediate adhesion to agrin and modulate agrin signaling","volume":"124","author":"Martin","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.omtm.2021.02.004_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1083\/jcb.200611152","article-title":"Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages","volume":"176","author":"Meinen","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib44","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1096\/fj.04-3376com","article-title":"Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice","volume":"19","author":"Bentzinger","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2021.02.004_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.01.005","article-title":"Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin","volume":"9","author":"Qiao","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.02.004_bib46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/dneu.20953","article-title":"Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction","volume":"71","author":"Singhal","year":"2011","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.omtm.2021.02.004_bib47","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1523\/JNEUROSCI.20-11-04099.2000","article-title":"Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies","volume":"20","author":"Jenniskens","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2021.02.004_bib48","doi-asserted-by":"crossref","first-page":"e00140-19","DOI":"10.1128\/MCB.00140-19","article-title":"Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes","volume":"39","author":"Cramer","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib49","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.87.9.3264","article-title":"Merosin, a tissue-specific basement membrane protein, is a laminin-like protein","volume":"87","author":"Ehrig","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.02.004_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JND-170217","article-title":"Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-\u03b12 Related Congenital Muscular Dystrophy","volume":"4","author":"Willmann","year":"2017","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.omtm.2021.02.004_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/s0960-8966(02)00266-3","article-title":"Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice","volume":"13","author":"Guo","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2021.02.004_bib52","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/hmg\/ddr126","article-title":"Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A","volume":"20","author":"Kumar","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.02.004_bib53","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2021.02.004_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2353\/ajpath.2007.060927","article-title":"Overexpression of the cytotoxic T\u00a0cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A","volume":"171","author":"Xu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2021.02.004_bib55","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1242\/jcs.083311","article-title":"Transgenic overexpression of the \u03b17 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A","volume":"124","author":"Doe","year":"2011","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2021.02.004_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/emboj\/17.2.335","article-title":"Electron microscopic structure of agrin and mapping of its binding site in laminin-1","volume":"17","author":"Denzer","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.omtm.2021.02.004_bib57","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1097-2765(00)80388-3","article-title":"The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin","volume":"4","author":"Hohenester","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtm.2021.02.004_bib58","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/S0021-9258(19)39691-7","article-title":"Heparin modulation of laminin polymerization","volume":"265","author":"Yurchenco","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.02.004_bib59","first-page":"1601","article-title":"Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency","volume":"79","author":"Kuang","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.omtm.2021.02.004_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/bbrc.1999.0829","article-title":"Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin alpha2-deficient mice","volume":"260","author":"Mukasa","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2021.02.004_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molmed.2006.04.003","article-title":"The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy","volume":"12","author":"Miller","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2021.02.004_bib62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/emmm.201100151","article-title":"Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice","volume":"3","author":"Meinen","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2021.02.004_bib63","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.02.004_bib64","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omtm.2021.02.004_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/dbio.1996.0057","article-title":"Synaptic integrins in developing, adult, and mutant muscle: selective association of alpha1, alpha7A, and alpha7B integrins with the neuromuscular junction","volume":"174","author":"Martin","year":"1996","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2021.02.004_bib66","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ajpath.2016.05.021","article-title":"B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I","volume":"186","author":"Thomas","year":"2016","journal-title":"Am. J. Pathol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012100019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012100019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:29:09Z","timestamp":1762421349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012100019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":66,"alternative-id":["S232905012100019X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.02.004","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}